Nightingale Appoints New Executive Vice President of Sales

MARKHAM, ON, June 24, 2013 /CNW/ - Nightingale Informatix Corporation ("Nightingale" or the "Company") (TSX-V: NGH), a provider of cloud-based electronic medical record (EMR) software and related services, today announced the appointment of Mark Crerar as Executive Vice President of Sales, effective immediately.

"Mark's mandate will be to drive the Company's Enterprise EMR sales strategy for both Canada and the United States. A key element in this will be building a robust sales organization, timed with the release of our next-generation EMR product, Nexia™.  We are very pleased having been able to attract someone of Mark's caliber.  He has deep expertise in enterprise-level technology sales, having worked at the management and executive level for North American industry leaders such as IBM and Unisys," said Sam Chebib, President & CEO of Nightingale. "We are excited to welcome him to the team."

Over the span of his 25-year career, Mark has held leadership positions in technology sales and business development with IBM, Unisys, Hitachi Data Systems and Hewlett Packard, working with customers and partners in both Canada and the United States.  Prior to joining Nightingale, he was responsible for Hewlett Packard's Enterprise Business in Central Canada, servicing corporate, enterprise and mid-market customers from multiple industries, including Life Sciences and Healthcare. Mark has a BA from Yale University and MBA from Schulich School of Business.

Over the last 18 months Nightingale has been diligently attracting talented executives that will help the company scale the next phase of its growth.  During this period, Nightingale has appointed new leadership to key positions across the organization, including Finance, Operations, IT, Professional Services, Human Resources, and Marketing.  The Company's technology and its strengthened management structure have put Nightingale in an excellent position to capitalize on the numerous opportunities it has identified in the healthcare IT market across North America.

About Nightingale
Nightingale is one of the fastest growing health care service and software companies in North America and is recognized as an industry leader in Web-based clinician and community based electronic medical records (EMR) serving the needs of small primary care practices, multi-physician outpatient clinics, and large scale regional health organizations and networks. Coupled with integrated practice management and transcription, Nightingale's comprehensive service offering allows customers to enhance patient care, increase revenue opportunities and optimize operations. Nightingale is continuously innovating and enhancing its services to meet the needs of its growing and diverse customer base. Nightingale - Healthcare connected. www.nightingalemd.ca

Forward Looking Statement
This press release contains "forward-looking statements" respecting the issuance and cancellation of securities of the Company within the meaning of applicable Canadian securities legislation. Generally, forward-looking statements can be identified by the use of forward- looking terminology such as "plans", "expects" or "does not expect",  "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may" ,"could", "would", "might", "occur" or "be achieved". Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Nightingale to be materially different from those expressed or implied by such forward-looking statements, including but not limited to: risks related to the speculative nature of the medical software industry, which is affected by numerous factors beyond Nightingale's control; the ability of Nightingale to successfully secure customer contracts and the timing of securing such contracts; the ability of Nightingale to complete and successfully integrate its acquisitions on an accretive basis, Nightingale's access to debt and capital facilities, including compliance with current debt arrangements; the existence of present and possible future government regulation; the significant competition that exists in the medical software industry; the early stage of Nightingale's business, and risks associated with early stage companies, including uncertainty of revenues, markets and profitability and the need to raise additional funding.  All material assumptions used in making forward-looking statements are based on management's knowledge of current business conditions and expectations of future business conditions and trends. Certain material factors or assumptions applied by management in making forward-looking statements, include without limitation, factors and assumptions regarding future trends in healthcare spending, economic conditions affecting Nightingale and North American economies; Nightingale's ability to continue to fund its business, rates of customer defaults, relationships with, and payments to lenders, as well as Nightingale's operating cost structure.

Although Nightingale has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. Nightingale does not undertake to update any forward-looking statements that are incorporated by reference herein, except in accordance with applicable securities laws. Further information on Nightingale Informatix Corporation is available at www.sedar.com.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Nightingale Informatix Corporation

For further information about Nightingale, contact:

Media Inquiries
Lorraine McMeekin
Corporate Marketing Manager
Nightingale Informatix Corporation
Tel: [phone]
[email protected]

Investor Inquiries
Marc Lakmaaker 
Senior Account Executive
TMX Equicom 
Tel: [phone] ext. 248   
[email protected]